SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000882104-13-000006
Filing Date
2013-05-09
Accepted
2013-05-09 16:03:06
Documents
13
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pdli-2013331x10q.htm 10-Q 1095145
2 2014 LONG-TERM INCENTIVE PLAN pdli-2013331xex101.htm EX-10.1 13133
3 2013 ANNUAL BONUS PLAN pdli-2013331xex102.htm EX-10.2 22720
4 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES pdli-2013331xex121.htm EX-12.1 58026
5 CERTIFICATION pdli-2013331xex311.htm EX-31.1 11220
6 CERTIFICATION pdli-2013331xex321.htm EX-32.1 6741
13 pdlilogo.jpg GRAPHIC 7005
  Complete submission text file 0000882104-13-000006.txt   8174166

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pdli-20130331.xml EX-101.INS 1240784
8 XBRL TAXONOMY EXTENSION SCHEMA pdli-20130331.xsd EX-101.SCH 88673
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdli-20130331_cal.xml EX-101.CAL 42531
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdli-20130331_def.xml EX-101.DEF 226564
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdli-20130331_lab.xml EX-101.LAB 779511
12 XBRL TAXONOMY EXTENSION PRESENTION LINKBASE pdli-20130331_pre.xml EX-101.PRE 426015
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 13828592
SIC: 2836 Biological Products, (No Diagnostic Substances)